Member Posts > Cardiol Therapeutics to Showcase Advancements in Inflammatory Heart Disease Treatment at TD Cowen Conference
Cardiol Therapeutics Inc., a pioneering biotechnology company focused on developing novel treatments for inflammatory and fibrotic heart diseases, will present its latest research and clinical updates at the TD Cowen 45th Annual Health Care Conference in Boston on March 5, 2025, at 11:10 AM EST.
The company has been at the forefront of developing innovative cardiovascular treatments, leveraging advanced scientific approaches to address unmet medical needs. Earlier this year, Cardiol Therapeutics participated in the Oppenheimer 35th Annual Healthcare Life Sciences Conference (February 2025), where it provided key insights into its growing research pipeline. Additionally, in September 2023, CEO David Elsley delivered a company overview at the Cantor Fitzgerald 2023 Global Healthcare Conference, emphasizing its vision for tackling inflammatory heart conditions.
By consistently engaging in major healthcare conferences, Cardiol Therapeutics strengthens its presence in the biotechnology space, ensuring that its groundbreaking therapies reach both investors and the medical community.

#CardiolTherapeutics #MedicalResearch #PharmaceuticalInnovation #HeartDiseaseTreatment #BiotechNews